Avvinity Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Liquidation
Avvinity Therapeutics General Information
Description
Developer of proprietary Alphamer-based 'antibody recruiting molecules' intended to treat solid and hematological cancers. The company's portfolio exemplifies the use of antibodies, antibody fragments, RNA/DNA, Aptamers, and small molecules as targeting domains, enabling healthcare institutes to access the technology for the treatment of both solid tumors and leukemia.
Contact Information
Website
www.avvinity.comCorporate Office
- First Floor
- 3-4 Holborn Circus
- London EC1N 2HA
- England, United Kingdom
Corporate Office
- First Floor
- 3-4 Holborn Circus
- London EC1N 2HA
- England, United Kingdom
Avvinity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 06-Sep-2022 | 00.000 | Completed | Bankruptcy: Liquidation | ||
| 5. Later Stage VC (Series A) | 0000 | Cancelled | Pre-Clinical Trials | |||
| 4. Seed Round | 01-Aug-2020 | 00.00 | 00.000 | Completed | Pre-Clinical Trials | |
| 3. Corporate | 06-Aug-2019 | 00000 | 00.000 | 0000 | Completed | Pre-Clinical Trials |
| 2. Corporate | 03-Aug-2018 | $1.84M | $1.84M | 000.00 | Completed | Pre-Clinical Trials |
| 1. Joint Venture | 02-Mar-2016 | $110M | 00000 | Completed | Startup |
Avvinity Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Avvinity Therapeutics Comparisons
Industry
Financing
Details
0000 0
000 00
Avvinity Therapeutics Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bolt Biotherapeutics | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000 | 00000 |
| IGM Biosciences | Formerly VC-backed | Mountain View, CA | 000 | 00000 | 000000000 | 00000 |
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| Mersana Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
| Curadev | Formerly VC-backed | Noida, India | 00 | 00.000 | 00000000000 | 00.000 |
Avvinity Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avvinity Therapeutics Patents
Avvinity Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202203283-D0 | Novel cysteine engineered antibodies and anitbody drug conjugates | Inactive | 09-Mar-2022 | ||
| GB-202104886-D0 | Novel aptamers and therapeutic uses thereof | Inactive | 06-Apr-2021 | ||
| AU-2019359499-A1 | Compounds and therapeutic uses thereof | Pending | 10-Oct-2018 | 00000000000 | |
| EP-3863718-A1 | Compounds and therapeutic uses thereof | Pending | 10-Oct-2018 | 00000000000 | |
| CA-3115371-A1 | Compounds and therapeutic uses thereof | Pending | 10-Oct-2018 | A61K47/6889 |
Avvinity Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Avvinity Therapeutics FAQs
-
When was Avvinity Therapeutics founded?
Avvinity Therapeutics was founded in 2016.
-
Who is the founder of Avvinity Therapeutics?
Darrin Disley Ph.D, Jonathan Moore Ph.D, and Michael Westby Ph.D are the founders of Avvinity Therapeutics.
-
Where is Avvinity Therapeutics headquartered?
Avvinity Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Avvinity Therapeutics?
Avvinity Therapeutics has 9 total employees.
-
What industry is Avvinity Therapeutics in?
Avvinity Therapeutics’s primary industry is Drug Discovery.
-
Is Avvinity Therapeutics a private or public company?
Avvinity Therapeutics is a Private company.
-
What is Avvinity Therapeutics’s current revenue?
The current revenue for Avvinity Therapeutics is 000000.
-
How much funding has Avvinity Therapeutics raised over time?
Avvinity Therapeutics has raised $6.51M.
-
Who are Avvinity Therapeutics’s competitors?
Bolt Biotherapeutics, IGM Biosciences, Sutro Biopharma, Mersana Therapeutics, and Curadev are some of the 6 competitors of Avvinity Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
